Onderzoeker
Yven Van Herrewege
Affiliaties
- Clinical Trials Unit (Onderzoekseenheid)
Lid
Vanaf17 jan 2000 → Heden - Instituut voor Tropische Geneeskunde (Onderzoeksinstituut)
Lid
Vanaf16 jan 2000 → 30 okt 2007
Projecten
1 - 2 of 2
Publicaties
1 - 10 van 23
- Antimalarial artesunate-mefloquine versus praziquantel in African children with schistosomiasis: an open-label, randomized controlled trial(2024)
Auteurs: E Bottieau, Moustapha Mbow, Isabel Brosius, Clémentine Roucher, Cheikh Tidiane Gueye, Ousmane Thiam Mbodj, Babacar Thiendella Faye, Annelies De Hondt, Bart Smekens, Diana Arango, et al.
Pagina's: 130-137 - Five accelerated schedules for the tick-borne encephalitis vaccine FSME-Immun® in last-minute travellers: an open-label, single-Centre, randomized controlled pilot trial(2023)
Auteurs: Nicole Berens-Riha, Petra Andries, Annelies Aerssens, Quentin Ledure, Yolien Vanderbeken, L Heyndrickx, Els Genbrugge, Achilleas Tsoumanis, Yven Van Herrewege, Kevin Ariën, et al.
- Evaluation of artesunate-mefloquine as a novel alternative treatment for schistosomiasis in African children (SchistoSAM): protocol of a proof-of-concept, open-label, two-arm, individually-randomised controlled trial(2021)
Auteurs: Clémentine Roucher, Isabel Brosius, Moustapha Mbow, Babacar Thiendella Faye, Annelies De Hondt, Bart Smekens, Diana Arango, Christophe Burm, Achilleas Tsoumanis, Linda Paredis, et al.
- Antibacterial mouthwash to prevent sexually transmitted infections in men who have sex with men taking HIV pre-exposure prophylaxis (PReGo): a randomised, placebo-controlled, crossover trial(2021)
Auteurs: Achilleas Tsoumanis, Anke Rotsaert, Bea Vuylsteke, Dorien Van den Bossche, Elke Paeleman, Irith De Baetselier, Isabel Brosius, Jolein Laumen, Jozefien Buyze, Kristien Wouters, et al.
Pagina's: 657-667 - Chlorhexidine mouthwash fails to eradicate oropharyngeal gonorrhea in a clinical pilot trial (MoNg)(2021)
Auteurs: Achilleas Tsoumanis, Annelies De Hondt, Vicky Cuylaerts, Jolein Laumen, Yven Van Herrewege, Eric Florence, Irith De Baetselier, Chris Kenyon
Pagina's: e38-e41 - Vaccinating children in high-endemic rabies regions: what are we waiting for?(2021)
Auteurs: Patrick Soentjens, Nicole Berens-Riha, Yven Van Herrewege, Pierre Van Damme, Emmanuel Bottieau, Raffaella Ravinetto
- Time of administration of rabies immunoglobulins and adequacy of antibody response upon post-exposure prophylaxis: a descriptive retrospective study in Belgium(2019)
Auteurs: Patrick Soentjens, Mieke Croughs, Christophe Burm, Steven Declerq, J Clerinx, Ula Maniewski-Kelner, Steven Van Den Broucke, Caroline Theunissen, Ralph Huits, Isabel Brosius, et al.
Pagina's: 91-97 - Comparative immunogenicity and safety trial of 2 different schedules of single-visit intradermal rabies postexposure vaccination(2019)
Auteurs: Patrick Soentjens, Katrien De Koninck, Achilleas Tsoumanis, Natacha Herssens, Dorien Van Den Bossche, Sanne Terryn, Steven Van Gucht, Pierre Van Damme, Y Van Herrewege, Emmanuel Bottieau
Pagina's: 797-804 - Pre-exposure intradermal rabies vaccination: a non-inferiority trial in healthy adults on shortening the vaccination schedule from 28 to 7 days(2019)
Auteurs: Patrick Soentjens, P Andries, A Aerssens, Achilleas Tsoumanis, Raffaella Ravinetto, W Heuninckx, Harry Van Loen, B Brochier, S. Van Gucht, P Van Damme, et al.
Pagina's: 607-614 - In vitro synergistic activity against CCR5-tropic HIV-1 with combinations of potential candidate microbicide molecules HHA, KRV2110 and enfuvirtide (T20)(2009)
Auteurs: MA Jenabian, H Saïdi, C. Charpentier, Y Van Herrewege, JC Son, D Schols, J Balzarini, G Vanham, L Bélec
Pagina's: 1192-1195